{"created":"2020-10-13T09:38:26.332233+00:00","id":5744,"links":{},"metadata":{"_buckets":{"deposit":"ed7fe7b8-4f2f-43df-9b2c-b3d77756ab33"},"_deposit":{"created_by":37,"id":"5744","owner":"37","owners":[37],"owners_ext":{"displayname":"","email":"Papaaung99@gmail.com","username":""},"pid":{"revision_id":0,"type":"recid","value":"5744"},"status":"published"},"_oai":{"id":"oai:meral.edu.mm:recid/5744","sets":["1582963366982:1597649781428"]},"communities":["um1"],"item_1583103067471":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_1551255647225":"Clinical Study of Oestrogen Reception, Progesterone Receptor and HER2/ NEU Receptor Expression Status in Breast Cancer Patients","subitem_1551255648112":"en"}]},"item_1583103085720":{"attribute_name":"Description","attribute_value_mlt":[{"interim":"Hospital-based descriptive study was done from January 2017 to December 2017. The study was carried out in 100 breast cancer patients, attending the Medical Oncology Department of Yangon General Hospital by using convenience non-probability sampling method. The positive expression rate of ER, PR receptors observed were 53% and 57 % respectively. Her2/neu positive expression was 34% and equivocal (8%). The mean age of breast cancer patients was 51.1 years with the youngest being 26 and the oldest,78."}]},"item_1583103108160":{"attribute_name":"Keywords","attribute_value_mlt":[{"interim":"Oestrogen Receptor"},{"interim":"Progesterone Receptor"},{"interim":"HER2/NEU Receptor"},{"interim":"Breast Cancer"}]},"item_1583103120197":{"attribute_name":"Files","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2020-10-13"}],"displaytype":"preview","filename":"journal of ER,PR,HER2 in breast cancer patients.pdf","filesize":[{"value":"524 Kb"}],"format":"application/pdf","licensetype":"license_1","url":{"url":"https://meral.edu.mm/record/5744/files/journal of ER,PR,HER2 in breast cancer patients.pdf"},"version_id":"88459b78-d975-49af-a355-4fb4f3f1fbf2"}]},"item_1583103131163":{"attribute_name":"Journal articles","attribute_value_mlt":[{"subitem_issue":"1","subitem_journal_title":"Research Journal UM1","subitem_pages":"64-71","subitem_volume":"1"}]},"item_1583105942107":{"attribute_name":"Authors","attribute_value_mlt":[{"subitem_authors":[{"subitem_authors_fullname":"Ei Hay Mar Myint Yi"},{"subitem_authors_fullname":"Wai Wai Lwin"},{"subitem_authors_fullname":"Khin Thin Mu"},{"subitem_authors_fullname":"Myo Myint Maw"}]}]},"item_1583108359239":{"attribute_name":"Upload type","attribute_value_mlt":[{"interim":"Publication"}]},"item_1583108428133":{"attribute_name":"Publication type","attribute_value_mlt":[{"interim":"Journal article"}]},"item_1583159729339":{"attribute_name":"Publication date","attribute_value":"2020-02-15"},"item_title":"Clinical Study of Oestrogen Reception, Progesterone Receptor and HER2/ NEU Receptor Expression Status in Breast Cancer Patients","item_type_id":"21","owner":"37","path":["1597649781428"],"publish_date":"2020-10-13","publish_status":"0","recid":"5744","relation_version_is_last":true,"title":["Clinical Study of Oestrogen Reception, Progesterone Receptor and HER2/ NEU Receptor Expression Status in Breast Cancer Patients"],"weko_creator_id":"37","weko_shared_id":-1},"updated":"2021-12-13T05:21:11.043634+00:00"}